Overview
Richard Hughes leverages his background as a health lawyer and industry executive to help health care and life sciences entities navigate a broad range of legal, regulatory, policy, and business strategy issues.
Richard provides strategic business counsel to clients, assembles multidisciplinary teams, and builds market strategies for product development and growth. He also provides counsel, with a particular emphasis on vaccines, prevention, and early intervention, to biopharmaceutical and device companies and a variety of health care clients and offers clients guidance on coverage, payment, legal, regulatory, and policy issues.
Richard previously served as Managing Director at a leading Washington health care advisory firm and Vice President at a major vaccine manufacturer during the COVID-19 pandemic. Prior to that, as an attorney at the law firm Epstein Becker Green, Richard advised a national government on the implementation of a single-payor health insurance system and guided clients through the implementation of the Affordable Care Act and the Medicare Access and CHIP Reauthorization Act.
Earlier in his career, Richard served in several health policy leadership roles. He was a gubernatorial appointee to the Arkansas State Board of Health, where he deliberated regulatory policy, presided over appeals before the state health department, and advocated for vaccine access. Richard has also held roles at the Association of State and Territorial Health Officials and with another leading biopharmaceutical company.
Richard has led many successful efforts to expand access to vaccines and preventive services. His thought leadership and problem-solving strategies have broken barriers to access to vaccines and PrEP for HIV, and his advice on vaccine policy is sought after by leading manufacturers, members of Congress, federal agencies, and the broader advocacy community.
Richard is a Professorial Lecturer in Law at The George Washington University Law School and previously a Professorial Lecturer in Health Policy & Management at the Milken Institute School of Public Health. During law school, Richard served as a legal research assistant to Professor Sara Rosenbaum, renowned health law scholar and Founding Chair of the Department of Health Policy at the Milken Institute School of Public Health. Richard has published in Health Affairs and in law and medical journals, and he is a regular contributor to Health Affairs Forefront.
Read less
Focus Areas
Services
Recognition
- Delta Omega Honorary Society in Public Health
- Health Affairs, Top 10 Most-Read Health Affairs Blog Posts of 2019 (No. 9) (2019)
- University of Arkansas for Medical Sciences, Fay W. Boozman College of Public Health, Center Stage Alumni (2021)
Credentials
Education
- The George Washington University Law School (J.D.)
- Health Law
- University of Arkansas for Medical Sciences (M.P.H.)
- Arkansas State University (B.S.)
Professional & Community Involvement
- American Bar Association, Health Law Section
- American Health Lawyers Association
- American Journal of Public Health, Peer-Reviewer
- American Public Health Association
- American Society of Law, Medicine, and Ethics
- Arkansas State Board of Health (Gubernatorial Appointment) (2006 to 2009)
- National Vaccine Law Conference, Steering Committee
Events
Past Events
Insights
Insights
- PublicationsIs CMS Ignoring the Realities of Biopharmaceutical Costs?2 minute read
- PublicationsFederal Judge in Texas Strikes Down ACA's Preventive Services Coverage Mandate12 minute read
- PublicationsCMS Can Fix Medicare Vaccine Coverage to Protect Seniors from RSV4 minute read
- Media CoverageInsulin as Preventive Care: Why Not Eliminate Patient Cost Sharing?4 minute read
- PublicationsA Patchwork in Need of Permanent Repair: The U.S. Framework for Recommending and Covering Preventive Care2 minute read
- PublicationsReflecting on the Future of US Vaccine Programs2 minute read
- Media CoverageRichard Hughes, Spreeha Choudhury Featured in “Loosening Restrictions on Pharmacists Could Help Raise Children’s ...4 minute read
- PublicationsRecognizing Pharmacists as Vaccines for Children Providers2 minute read
- PublicationsMarking the End of an Era: The COVID-19 Vaccine Market Goes Commercial3 minute read
- PublicationsWhy Are We Delaying Coverage of New HIV Prevention?2 minute read
- PublicationsCOVID-19 Vaccine Prices Are Going Up. It Shouldn’t Be Our Focus.2 minute read
- PublicationsWill the US Supreme Court Strike Down the ACA’s Preventive Services Coverage Requirement?September 23, 20222 minute read
- PublicationsCongress Finally Eliminates Part D Vaccine Cost Sharing: Medicare Coverage Is Still BrokenAugust 26, 20223 minute read
- PublicationsCOVID-19 Vaccination and the Fetal Cell Line Conundrum for Employee Religious ObjectionsAugust 11, 202210 minute read
- PublicationsCOVID-19 Vaccine and Monoclonal Coverage: A Focus of the 2023 Medicare Physician Fee Schedule Proposed RuleAugust 1, 202210 minute read
- Media CoverageRichard Hughes’ Article on Immunization Access Cited in “A Twenty-First Century 'Vaccines for Children' Program” ...July 12, 20223 minute read
Experience
- Develops federal and state policy strategies for vaccine and other biopharmaceutical manufacturers, and advises clients on strategies for engaging state and federal agencies, including FDA, CDC, CMS, and BARDA.
- Counsels investors and startups on market trends and developments in health care, including identifying total addressable markets. Richard also facilitates multidisciplinary expert input and advisory boards for clients.
- Advises multiple manufacturers on launch strategy for new vaccines and other products.
- Advises novel, non-vaccine developers on strategies for obtaining a “vaccine-like” recommendation, coverage, and reimbursement pathway.
- Influences public policy development as a thought leader in the field of preventive health care and public health. Richard advised or engaged the White House, HHS, CDC, HHS, and Congressional offices on the development of vaccine policy.
- Conducted many 50-state analyses of laws, regulations, and Medicaid coverage policies, as well as payor coverage analyses. Richard led studies using survey methods and claims-based analyses of vaccine-preventable disease burden and uptake in Medicare and other markets.